Isothiazolinone microcapsule as well as preparation method and application thereof
By using urea formaldehyde resin as the wall material and isothiazolinone as the core material, the stability and sustained release problems of isothiazolinone microcapsules are solved, and long-term antibacterial and bactericidal ability is achieved, which is suitable for E. coli and Effective killing of Staphylococcus aureus.
Patent Information
- Application Number
- CN202411161165.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-29
AI Technical Summary
The existing isothiazolinone microcapsules have problems such as low stability, inability to expand production, weak sterilization performance, and poor sustained release effect.
Sodium dodecylbenzenesulfonate, polyvinyl alcohol, isothiazolinone as core solution, urea, aqueous formaldehyde solution, ammonium sulfate, melamine and zinc sulfate as wall material, isothiazolin is prepared by interfacial polymerization method Keto microcapsules, adjust the core wall ratio to 2:1 to improve stability and sustained release efficiency.
It improves the stability and sustained release performance of isothiazolinone microcapsules, achieves long-acting antibacterial and bactericidal ability, and is suitable for the effective killing of E. coli and Staphylococcus aureus.
Smart Images

Figure CN119032940A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of microcapsule preparation, and more specifically to isothiazolinone microcapsule and a preparation method and application thereof. Background Art
[0002] Among many fungicides, green and environmentally friendly isothiazolinone derivatives have broad application prospects due to their excellent fungicidal properties, easy degradation and environmentally friendly characteristics. However, isothiazolinone derivatives have weak stability and are prone to photodegradation during use, thus losing their fungicidal activity. In complex environments, they may also undergo chemical hydrolysis and biodegradation, so certain measures need to be taken to improve their stability.
[0003] Microcapsules refer to solid particles formed by encapsulating active substances in different states in polymers by physical or chemical methods, in which the internal active substances are called core materials, and the outer layer materials surrounding the core materials are called wall materials. The active substances treated with microcapsules can change their state of existence without changing their performance, which greatly broadens the use scenarios. The sustained release, protectiveness and compatibility of microcapsules make them widely used in various fields. The present invention adopts microcapsule technology to prepare isothiazolinone microcapsules, which slow down the release rate of the bactericide while improving stability, so that it has long-lasting antibacterial and bactericidal capabilities.
[0004] Liu Mingguang et al. (Liu Mingguang, Liu Yu, Zhao Ru. Preparation, characterization and release behavior of isothiazolinone microcapsules [J]. Polymer Materials Science and Engineering, 2021, 37 (2): 49-53) prepared an isothiazolinone microcapsule using polyurethane as the wall material, but polyurethane has the problems of low mechanical strength and low stability. Zhang Xiaohua et al. (Zhang Xiaohua, Lu Jianlan, He Renhong. Preparation and anti-mildew effect of isothiazolinone microcapsule antifungal agent [J]. China Leather, 2018, 47 (8): 4.) prepared an isothiazolinone microcapsule antifungal agent using gelatin and gum arabic as the wall material, but because gelatin and gum arabic are not artificially synthesized, the composition is unclear, there may be impurities, and the batch variability is large, it is not suitable for expanded production. In addition, the isothiazolinone microcapsules prepared according to the above literature also have the problem of poor sustained release effect. Summary of the invention
[0005] The purpose of the present invention is to provide an isothiazolinone microcapsule and a preparation method and application thereof, so as to solve the problems of low stability, inability to expand production, weak bactericidal performance and poor sustained-release effect of the isothiazolinone microcapsule prepared in the prior art.
[0006] In order to solve the above problems, the present invention adopts the following technical solutions:
[0007] According to a first aspect of the present invention, a method for preparing isothiazolinone microcapsules is provided, comprising the following steps: 1) dispersing sodium dodecylbenzene sulfonate and polyvinyl alcohol in distilled water, adding isothiazolinone and xylene solvent, mixing and stirring for emulsification, and obtaining a microcapsule core material solution, wherein the mass ratio of sodium dodecylbenzene sulfonate, polyvinyl alcohol, and isothiazolinone is 1:2:(20-160); 2) uniformly mixing urea, formaldehyde aqueous solution, ammonium sulfate, melamine, and zinc sulfate to obtain a microcapsule wall material solution. , wherein the mass ratio of urea, formaldehyde aqueous solution, ammonium sulfate, melamine and zinc sulfate is (8-9):(24-25):1:(4-5):1; 3) triethanolamine is added dropwise to the microcapsule core material solution, and a microcapsule wall material solution is added to react, wherein the mass ratio of the microcapsule core material solution to the microcapsule wall material solution is 1:(0.2-2), and then the solution after the reaction is centrifuged, and the solid matter is dried, ground and sieved after centrifugation to obtain an isothiazolinone microcapsule with urea-formaldehyde resin as the wall material.
[0008] Preferably, in step 1), the mass ratio of sodium dodecylbenzene sulfonate, polyvinyl alcohol and isothiazolinone is 1:2:(20-100).
[0009] Preferably, in step 3), triethanolamine is added dropwise to adjust the pH of the solution to 8-9.
[0010] Preferably, in step 3), the mass ratio of the microcapsule core material solution to the microcapsule wall material solution is 1:(0.5-1).
[0011] Preferably, in step 3), the mass ratio of the microcapsule core material solution to the microcapsule wall material solution is 2:1.
[0012] Preferably, in step 3), triethanolamine is added dropwise to the microcapsule core material solution to adjust the pH of the solution to 8-9.
[0013] Preferably, in step 3), the reaction temperature is 70-80°C, the reaction time is 3-5h, the centrifugal speed is 7000-8000rpm, the centrifugal time is 10-20min, the drying temperature is 70-100°C, and the drying time is 10-12h.
[0014] According to a second aspect of the present invention, there is provided an isothiazolinone microcapsule prepared according to the above preparation method. The isothiazolinone microcapsule is prepared by interfacial polymerization using urea-formaldehyde resin as the wall material and isothiazolinone as the core material.
[0015] According to a third aspect of the present invention, there is provided an application of the above preparation method in preparing a bactericide, wherein the bactericide is used to kill Escherichia coli and Staphylococcus aureus.
[0016] In the preparation method of such isothiazolinone microcapsules provided by the present invention, step 2) and step 3) are the most important, which are the preparation process of microcapsule wall material and the synthesis process of microcapsules, respectively. In step 2), urea, formaldehyde aqueous solution, ammonium sulfate, melamine and zinc sulfate are used for the first time to synthesize urea-formaldehyde resin in the preparation of wall materials, which opens up the choice of wall materials when synthesizing isothiazolinone microcapsules, and the preparation process is simple and easy to operate, which is suitable for the mass production and application of isothiazolinone microcapsules. In step 3), isothiazolinone microcapsules with different core-to-wall ratios are prepared by adjusting the ratio of reactants and reaction conditions, and it is screened that when the core-to-wall ratio, that is, the mass ratio of the microcapsule core material solution to the microcapsule wall material solution is 2:1, the prepared isothiazolinone microcapsules have the best performance, and compared with the data in other prior arts, they have better coverage and sustained release efficiency.
[0017] The key invention of the present invention is that urea-formaldehyde resin is used as the wall material, which opens up a feasible wall material option for synthesizing isothiazolinone microcapsules. And according to the optimized preparation process of the present invention, the experimental conditions for successfully preparing isothiazolinone microcapsules will exceed the range, resulting in low synthesis yield or poor sustained-release effect and antibacterial effect of the microcapsules. Many studies have confirmed that microcapsules with urea-formaldehyde resin as the wall material have better sustained-release effect and longer lasting effect than polyurethane as the wall material. Therefore, the microcapsule wall material of the present invention has significant advantages over the microcapsule wall material in the prior art.
[0018] Compared with the prior art, the present invention has the following beneficial effects:
[0019] The present invention uses urea-formaldehyde resin synthesized from formaldehyde, urea, ammonium sulfate, melamine and zinc sulfate as raw materials as wall material, isothiazolinone as core material, and adopts interfacial polymerization to prepare isothiazolinone microcapsules. Isothiazolinone is an environmentally friendly fungicide, and microencapsulation improves its stability, so that it has long-lasting antibacterial properties. The method has a simple preparation process and strong operability, and is suitable for mass production and application of isothiazolinone microcapsules. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] Figure 1 The curves of release concentration of microcapsules with different core-to-wall ratios versus time are shown;
[0021] Figure 2 The graph shows the antibacterial results at different dosages of isothiazolinone microcapsules. DETAILED DESCRIPTION
[0022] The present invention will be further described below in conjunction with specific examples. It should be understood that the following examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional operations in the art, or according to the experimental methods recommended by the kit and instrument manufacturers. The reagents and materials used in the examples can be obtained from commercial sources unless otherwise specified.
[0023] Example 1
[0024] 0.100 g of sodium dodecylbenzene sulfonate and 0.200 g of polyvinyl alcohol were dispersed in a beaker containing 140.0 mL of distilled water and stirred at 600 rpm on a constant temperature heated magnetic stirrer. During this period, 2.630 g of isothiazolinone and 20.0 mL of xylene solvent were added thereto for emulsification. The stirring was stopped after 30 minutes to obtain a microcapsule core material solution.
[0025] 2.500 g of urea, 6.750 g of formaldehyde aqueous solution, 0.280 g of ammonium sulfate, 1.400 g of melamine and 0.280 g of zinc sulfate were mixed uniformly to obtain a microcapsule wall material solution.
[0026] 5 mol / L triethanolamine was added dropwise to a microcapsule core material solution containing 2.630 g of isothiazolinone to adjust the pH to 8.5, and 5.260 g of microcapsule wall material solution was added, and the mixture was reacted at a constant temperature of 75°C for 4 hours. After the temperature dropped to room temperature, the mixture was centrifuged at 7500 rpm for 20 minutes. The solid matter was taken out and placed in a culture dish and dried at 80°C for 12 hours. Finally, the isothiazolinone microcapsules with a core-to-wall ratio of 1:2 were obtained after grinding and sieving. The yield of the obtained microcapsules was 63.52%, and the coverage rate was 74.30%.
[0027] Example 2
[0028] 0.100 g of sodium dodecylbenzene sulfonate and 0.200 g of polyvinyl alcohol were dispersed in a beaker containing 140.0 mL of distilled water and stirred at 600 rpm on a constant temperature heated magnetic stirrer. During this period, 5.260 g of isothiazolinone and 20.0 mL of xylene solvent were added thereto for emulsification. The stirring was stopped after 30 minutes to obtain a microcapsule core material solution.
[0029] 2.500 g of urea, 6.750 g of formaldehyde aqueous solution, 0.280 g of ammonium sulfate, 1.400 g of melamine and 0.280 g of zinc sulfate were mixed uniformly to obtain a microcapsule wall material solution.
[0030] 5 mol / L triethanolamine was added dropwise to a microcapsule core material solution containing 5.260 g of isothiazolinone to adjust the pH to 8.5, and 5.260 g of microcapsule wall material solution was added, and the mixture was reacted at a constant temperature of 75°C for 4 hours. After the temperature dropped to room temperature, the mixture was centrifuged at 7500 rpm for 20 minutes. The solid matter was taken out and placed in a culture dish and dried at 80°C for 12 hours. Finally, the isothiazolinone microcapsules with a core-to-wall ratio of 1:1 were obtained after grinding and sieving. The yield of the obtained microcapsules was 71.34%, and the coverage rate was 78.20%.
[0031] Example 3
[0032] 0.100 g of sodium dodecylbenzene sulfonate and 0.200 g of polyvinyl alcohol were dispersed in a beaker containing 140.0 mL of distilled water and stirred at 600 rpm on a constant temperature heated magnetic stirrer. During this period, 10.520 g of isothiazolinone and 20.0 mL of xylene solvent were added thereto for emulsification. The stirring was stopped after 30 minutes to obtain a microcapsule core material solution.
[0033] 2.500 g of urea, 6.750 g of formaldehyde aqueous solution, 0.280 g of ammonium sulfate, 1.400 g of melamine and 0.280 g of zinc sulfate were mixed uniformly to obtain a microcapsule wall material solution.
[0034] 5 mol / L triethanolamine was added dropwise to a microcapsule core material solution containing 10.520 g of isothiazolinone to adjust the pH to 8.5, and 5.260 g of microcapsule wall material solution was added. The mixture was reacted at a constant temperature of 75°C for 4 h. After the temperature dropped to room temperature, the mixture was centrifuged at 7500 rpm for 20 min. The solid matter was taken out and placed in a culture dish and dried at 80°C for 12 h. Finally, the isothiazolinone microcapsules with a core-to-wall ratio of 2:1 were obtained after grinding and sieving. The yield of the obtained microcapsules was 81.49%, and the coverage rate was 82.60%.
[0035] Example 4
[0036] 0.100 g of sodium dodecylbenzene sulfonate and 0.200 g of polyvinyl alcohol were dispersed in a beaker containing 140.0 mL of distilled water and stirred at 600 rpm on a constant temperature heated magnetic stirrer. During this period, 15.780 g of isothiazolinone and 20.0 mL of xylene solvent were added thereto for emulsification. The stirring was stopped after 30 minutes to obtain a microcapsule core material solution.
[0037] 2.500 g of urea, 6.750 g of formaldehyde aqueous solution, 0.280 g of ammonium sulfate, 1.400 g of melamine and 0.280 g of zinc sulfate were mixed uniformly to obtain a microcapsule wall material solution.
[0038] 5 mol / L triethanolamine was added dropwise to a microcapsule core material solution containing 15.780 g of isothiazolinone to adjust the pH to 8.5, and 5.260 g of microcapsule wall material solution was added. The reaction was carried out at a constant temperature of 75°C for 4 hours. After the temperature dropped to room temperature, the solution was centrifuged at 7500 rpm for 20 minutes. The solid matter was taken out and placed in a culture dish and dried at 80°C for 12 hours. Finally, the isothiazolinone microcapsules with a core-to-wall ratio of 3:1 were obtained after grinding and sieving. The yield of the obtained microcapsules was 70.23%, and the coverage rate was 84.20%.
[0039] In Examples 1-4, isothiazolinone microcapsules were prepared respectively by adjusting the core-to-wall ratio. By calculating the yield and coverage rate of the microcapsules under different conditions, it was determined that the optimal core-to-wall ratio was 2:1. Therefore, the subsequent antibacterial performance experiment in Example 6 was conducted using isothiazolinone microcapsules with a core-to-wall ratio of 2:1.
[0040] Example 5 Release performance experiment of isothiazolinone microcapsules
[0041] The concentration and the absorbance of the solution at 274 nm (A 274 ) as the horizontal and vertical coordinates, draw the standard curve of isothiazolinone aqueous solution, and test the absorbance of isothiazolinone microcapsule solutions with different core-to-wall ratios. According to the diffusion rate equation of microcapsules in the aqueous phase (Formula 1), the equation 2 is obtained by integrating the obtained data points into Formula 2 and fitting with the nonlinear function Boxlucas1 to obtain the diffusion rate constant k under different conditions, and then the microcapsule release rate is obtained. Figure 1 The curves of release concentration of microcapsules with different core-to-wall ratios versus time are shown.
[0042] c t =c eq (1-e -kt ) (2)
[0043] where c t is the concentration of isothiazolinone in the solution at time t, c eq is the concentration of isothiazolinone in the solution at equilibrium, expressed in mg / mL, and k is the diffusion rate constant.
[0044] Table 1 Curve equations and parameters of microcapsules with different core-to-wall ratios after fitting
[0045] The fitting equations in Table 1 more directly show the equilibrium concentration and release rate of microcapsules with different core-to-wall ratios. 2 is the goodness of fit value of the curve. It can be seen that the goodness of fit of all curves R 2 The values are all relatively high, indicating that the fitting results are good and consistent with the basic law of microcapsule release.
[0046] where c eq is the concentration of isothiazolinone in the solution at equilibrium, in mg / mL. Generally speaking, the larger the value, the better. As the core-to-wall ratio increases, the concentration c of the microcapsule at equilibrium eq This is consistent with the law of the core material coverage of the microcapsule, indicating that a higher coverage rate can make the concentration of isothiazolinone in the environment higher, which is more conducive to its function.
[0047] Among them, k is the diffusion rate constant, which is used to characterize the sustained release ability of the microcapsule. The smaller the k value, the more difficult it is for the system to reach equilibrium. At this time, the slower the release rate of the microcapsule, that is, the better the sustained release performance. However, when the k value is too low, it means that the microcapsule is difficult to release outward and cannot meet the actual application needs. When the core-to-wall ratio is 1:2, the k value is small. At this time, the release rate of the microcapsule is slow and it is difficult to reach the equilibrium state. After increasing the core-to-wall ratio, the k value increases. Among them, the k values of the core-to-wall ratios of 1:1 and 2:1 are close, but the latter has a higher equilibrium concentration. When the core-to-wall ratio is 3:1, the k value of the microcapsule increases greatly. At this time, the microcapsule only takes a very short time to reach the equilibrium state and basically has no sustained release performance.
[0048] Therefore, combined with the measurement results of yield and coverage rate in Examples 1-4, the optimal core-to-wall ratio was obtained to be 2:1. Therefore, the antibacterial performance in the subsequent Example 6 was tested using isothiazolinone microcapsules with a core-to-wall ratio of 2:1.
[0049] Example 6 Antibacterial performance experiment of isothiazolinone microcapsules
[0050] In six bottles of 100 mL E. coli solution (6 × 10 5 CFU / mL) and six bottles of 100mL Staphylococcus aureus solution (6×10 5 CFU / mL) were added with 0mg, 5.0mg, 10.0mg, 15.0mg, 20.0mg and 25.0mg of isothiazolinone microcapsules with a core-to-wall ratio of 2:1, respectively, and placed at 36.5°C and 37°C for shaking culture for 24h. After the culture was completed, the bacterial solution was diluted 100 times, 1.0mL was spread on the plate and continued to be cultured under the above constant temperature conditions. After 24h, the plate was taken out for colony counting. Each group of experiments was repeated three times, and the antibacterial rate was calculated: antibacterial rate = (number of colonies in the experimental group - number of colonies in the blank group) / number of colonies in the experimental group × 100%.
[0051] Table 2 Antibacterial rate at different dosages of isothiazolinone microcapsules
[0052] When the amount of isothiazolinone microcapsules added was 5.0 mg, the antibacterial rates of Escherichia coli and Staphylococcus aureus were 98.85% and 99.13% respectively, that is, the isothiazolinone microcapsules had excellent bactericidal performance at a lower dosage. With the increase of the amount of isothiazolinone added, the antibacterial rate gradually increased. When the dosage was 25.0 mg, the antibacterial rates of both bacteria were close to 100%. The experimental results proved that the microcapsules have excellent bactericidal properties and can effectively inhibit or even kill microorganisms in a timely manner.
[0053] The above is only a preferred embodiment of the present invention, and is not intended to limit the scope of the present invention. The above embodiments of the present invention can also be modified in various ways. All simple, equivalent changes and modifications made according to the claims and the description of the present invention fall within the scope of protection of the claims of the present invention. The contents not described in detail in the present invention are all conventional technical contents.
Claims
1. A method for preparing isothiazolinone microcapsules, characterized in that: The steps include: 1) dispersing sodium dodecylbenzene sulfonate and polyvinyl alcohol in distilled water, adding isothiazolinone and xylene solvent, mixing and stirring for emulsification, and obtaining a microcapsule core material solution, wherein the mass ratio of sodium dodecylbenzene sulfonate, polyvinyl alcohol, and isothiazolinone is 1:2:(20-160); 2) uniformly mixing urea, formaldehyde aqueous solution, ammonium sulfate, melamine and zinc sulfate to obtain a microcapsule wall material solution, wherein the mass ratio of urea, formaldehyde aqueous solution, ammonium sulfate, melamine and zinc sulfate is (8-9):(24-25):1:(4-5):1; 3) Triethanolamine is added dropwise to the microcapsule core material solution, and a microcapsule wall material solution is added to react, wherein the mass ratio of the microcapsule core material solution to the microcapsule wall material solution is 1:(0.2-2), and then the solution after the reaction is centrifuged, and the solid matter is dried, ground and sieved to obtain an isothiazolinone microcapsule with urea-formaldehyde resin as the wall material.
2. The method for preparing isothiazolinone microcapsules according to claim 1, characterized in that: In step 1), the mass ratio of sodium dodecylbenzene sulfonate, polyvinyl alcohol and isothiazolinone is 1:2:(20-100).
3. The method for preparing isothiazolinone microcapsules according to claim 1, characterized in that: In step 3), triethanolamine is added dropwise to adjust the pH of the solution to 8-9.
4. The method for preparing isothiazolinone microcapsules according to claim 1, characterized in that: In step 3), the mass ratio of the microcapsule core material solution to the microcapsule wall material solution is 1:(0.5-1).
5. The method for preparing isothiazolinone microcapsules according to claim 4, characterized in that: In step 3), the mass ratio of the microcapsule core material solution to the microcapsule wall material solution is 2:
1.
6. The method for preparing isothiazolinone microcapsules according to claim 1, characterized in that: In step 3), triethanolamine is added dropwise to the microcapsule core material solution to adjust the pH value of the solution to 8-9.
7. The method for preparing isothiazolinone microcapsules according to claim 1, characterized in that: In step 3), the reaction temperature is 70-80°C, the reaction time is 3-5h, the centrifugal speed is 7000-8000rpm, the centrifugal time is 10-20min, the drying temperature is 70-100°C, and the drying time is 10-12h.
8. An isothiazolinone microcapsule prepared according to the preparation method according to any one of claims 1 to 7, characterized in that: The isothiazolinone microcapsules are prepared by using urea-formaldehyde resin as wall material and isothiazolinone as core material through interfacial polymerization.
9. Use of the preparation method according to any one of claims 1 to 7 in the preparation of a fungicide.
10. The use according to claim 9, characterized in that: The bactericide is used for killing Escherichia coli and Staphylococcus aureus.
Citation Information
Cited By
Microcapsule as well as preparation method and application thereof
CN122298305A
